Trial Profile
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2021
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- Sponsors Bracco Diagnostics
- 08 Aug 2018 Status changed from active, no longer recruiting to completed.
- 11 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Feb 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.